PUFA, genotypes and risk for cardiovascular disease

被引:28
|
作者
Panda, Chinmayee [1 ,2 ,3 ]
Varadharaj, Saradhadevi [3 ]
Voruganti, Venkata Saroja [1 ,2 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Nutr, Rm 3150,500 Laureate Way, Kannapolis, NC 28081 USA
[2] Univ North Carolina Chapel Hill, Nutr Res Inst, Rm 3150,500 Laureate Way, Kannapolis, NC 28081 USA
[3] Stand Proc Inc, Palmyra, WI USA
关键词
Genetic variants; Diet; Obesity; Cardiovascular disease; Inflammation; Oxidative stress; POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; FADS1-FADS2; GENE-CLUSTER; ALPHA-LINOLENIC ACID; INSULIN-RESISTANCE; OMEGA-3-FATTY-ACIDS SUPPLEMENTATION; MYOCARDIAL-INFARCTION; REINFARCTION TRIAL; METABOLIC SYNDROME; ARACHIDONIC-ACID;
D O I
10.1016/j.plefa.2021.102377
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyunsaturated fatty acids (PUFAs) are long chain fatty acids that are characterized by the presence of more than one double bond. These include fatty acids such as omega-3-alpha-linolenic acid (ALA) and omega-6 -linoleic acid (LA) which can only be obtained from dietary sources and are therefore termed essential fatty acids. They contain the building blocks for dihomo-gamma-linolenic acid and arachidonic acid in the omega-6 family as well as eicosapentaenoic acid and docosahexaenoic acid in the omega-3 family. Both ALA and LA are important constituents of animal and plant cell membranes and are important components of anti-inflammatory and pro-inflammatory hormones and therefore, often modulate cellular immunity under chronic inflammatory states. The variation in physiological PUFA levels is under significant genetic influence, the fatty acid desaturase (FADS) genes being key regulators of PUFA metabolism. These genetic variants have been shown to alter fatty acid metabolism and influence the onset and progression of various metabolic conditions. This detailed review discusses the role of PUFAs, diet and genotypes in risk for cardiovascular diseases.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Hypothyroidism and Risk of Cardiovascular Disease
    Gluvic, Zoran M.
    Zafirovic, Sonja S.
    Obradovic, Milan M.
    Sudar-Milovanovic, Emina M.
    Rizzo, Manfredi
    Isenovic, Esma R.
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (25) : 2065 - 2072
  • [42] Menopause and risk of cardiovascular disease
    Gensini, GF
    Micheli, S
    Prisco, D
    Abbate, R
    THROMBOSIS RESEARCH, 1996, 84 (01) : 1 - 19
  • [43] MicroRNAs and Cardiovascular Disease Risk
    Charles D. Searles
    Current Cardiology Reports, 2024, 26 : 51 - 60
  • [44] Migraine and risk of cardiovascular disease
    Kurth, Tobias
    Rohmann, Jessica L.
    Shapiro, Robert E.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
  • [45] Cardiovascular disease risk profiles
    Day, T. Eugene
    Goldlust, Eric
    AMERICAN HEART JOURNAL, 2010, 160 (01) : E3 - E3
  • [46] ETHNICITY AND RISK OF CARDIOVASCULAR DISEASE
    Khan, Nadia A.
    JOURNAL OF HYPERTENSION, 2023, 41 : E71 - E71
  • [47] Assessment of Cardiovascular Disease Risk
    Goldsborough III, Earl
    Osuji, Ngozi
    Blaha, Michael J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2022, 51 (03) : 483 - 509
  • [48] Glycemia and risk for cardiovascular disease
    Davidson, MB
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (03) : 227 - 227
  • [49] Kidney disease and cardiovascular risk
    Tonelli, Marcello
    Pfeffer, Marc A.
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 123 - 139
  • [50] The inheritance of cardiovascular disease risk
    Hanson, Mark
    ACTA PAEDIATRICA, 2019, 108 (10) : 1747 - 1756